BEAM•benzinga•
RBC Capital Maintains Sector Perform on Beam Therapeutics, Raises Price Target to $26
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 26, 2025 by benzinga